| Summary of Selected
Sections |
| Basics of Biopharmaceutics |
i) Biopharmaceutics and Pharmacokinetics (Biopharmaceutics
- definition and relating terms; Bioavailability - definition,
Cpvs t: AUC, Tmax, Cmax; Pharmacokinetics - definition, absorption,
disposition, elimination, kinetic analysis - models, parameters
- t1/2, K, (abs)t1/2, ka, Vd; Bioequivalence - definition, therapeutic
equivalence evaluation codes).
ii) Transport (Paracellular Transport; Passive Transport
- Ficks First Law; Endocytosis Transport; Carrier Mediated
Transport - active transport (primary and secondary, carrier-mediated
transport); A Theory of Mass Transport).
iii) Different Routes of Drug Administration (Routes of
Administration - buccal or sublingual, eye, IA, IM, inhalation,
IP, IV, nasal, rectal, SC, spinal, topical and vaginal).
|
Oral Drug Delivery
|
Gastrointestinal Tract
Factors
i) Anatomy and Morphology (Overview; Stomach; Small Intestine;
Large Intestine).
ii) Secretion (Salivary Secretion; Gastric Secretion; Pancreatic
Secretion; Biliary Secretion; Intestinal Secretion).
iii) Motility (Overview; Stomach - gastric emptying, fed
vs fasted state; Small Intestine - transit time, fed vs fasted
state; Large Intestine - transit time, fed vs fasted state).
v) Nutrient Absorption Effect (Fat; Carbohydrate; Protein).
Controlled Released Dosage Forms
i) Introduction.
ii) Terminology (Sustained Release; Controlled Release;
Zero-Order Release; First-Order Release).
iii) Factors Influencing CR (Biological Factors - elimination
rate, half-life, absorption, metabolism, duration of action; Physicochemical
Factors - dose size, ionization, pKa, aqueous solubility, partition
coef ficient, stability).
iv) Types of Oral CR (Diffusional Systems - reservoir devices,
matrix devices; Dissolution Controlled Systems; Diffusion and
Dissolution Controlled Systems; Osmotically Controlled Systems;
Ion-Exchange Systems).
v) Simulation (Defining Models; Nifedipine; Zero-Order
Release Simulations; First-Order Release Simulations).
vi) Regulation (Potential Bioavailability Problems - food
administration, First Pass Metabolism, Dose Dumping; Demonstration
of Safety and Efficacy; Dissolution Test).
|
|